is retatrutide a glp3 GLP-3 R 30mg GLP-3 20mg Vial (Retatrutide) |
Description
The Tolerability Tradeoff The most common adverse events in TRIUMPH-1 were familiar for incretin-based therapies: nausea, diarrhea, constipation, vomiting, and upper respiratory tract infection
Sulphonylureas and insulin carry an increased hypoglycaemia risk when combined with retatrutide
You want to start as quickly as possible Many doctors are booked out for weeks or months in advance
Cureus, 2021
